ELV vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

ELV

54.2
AI Score
VS
ELV Wins

CLOV

52.4
AI Score

Investment Advisor Scores

ELV

54score
Recommendation
HOLD

CLOV

52score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ELV CLOV Winner
Forward P/E 13.986 81.9672 ELV
PEG Ratio 1.3327 0 Tie
Revenue Growth 1.4% 55.6% CLOV
Earnings Growth -13.1% 0.0% CLOV
Tradestie Score 54.2/100 52.4/100 ELV
Profit Margin 2.5% -0.7% ELV
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CLOV

Relative Price Performance (Last 90 Days)

ELV 1M: +4.9% · 3M: +4.9% CLOV 1M: +6.2% · 3M: -1.6%

Current Technical Phase

ELV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.0 · Price: $418.72

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.4 · Price: $4.82

Fundamentals Snapshot

Metric ELV CLOV
Market Cap
Forward P/E 14.1 32.1
Trailing P/E 17.5
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.3% 0.2%
Operating Margin 0.0% 0.0%
EPS 23.74 -0.05
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, ELV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.